Back to results
US 2026/0263540 A1Published application
Glucuronidase activator, pharmaceutical composition, edible composition, and oral composition
AssigneeKaneka Corporation
InventorShinichi HONDA
Life of this patent
Estimating the term…
Abstract
A glucuronidase activator including an active ingredient that is a Levilactobacillus brevis strain I-3141 deposited under accession number CECT 7480.
Claims23
A glucuronidase activator comprising:
- an active ingredient that is a dried product or disrupted product of a Levilactobacillus brevis strain I-3141 deposited under accession number CECT 7480.
(canceled)
(canceled)
(canceled)
A method of enhancing glucuronidase activity, the method comprising:
- administering a dried product or disrupted product of a Levilactobacillus brevis strain I-3141 deposited under accession number CECT 7480 to a subject to enhance the glucuronidase activity.
An oral composition comprising:
- a dried product or disrupted product of a Levilactobacillus brevis strain I-3141 deposited under accession number CECT 7480;
- a dried product or disrupted product of Lactoplantibacillus plantarum deposited under accession number CECT 7481;
- and
- a dried product or disrupted product of Pediococcus acidilactici deposited under accession number CECT 7483.
1 more element
Dependencies are inferred from the claim text.